Search

Phase Genomics has partnered with Bill & Melinda Gates Foundation and National Institute of Allergy and Infectious Diseases to generate a global scale repository of phage-microbe interactions to create improved diagnostics and therapeutics.

News: Pherecydes Pharma announces the first international approval of a compassionate treatment with its phages.

Pre-print: CRISPR-Cas effector specificity and target mismatches determine phage escape outcomes.

Paper: Exodus: an open source tool for phage quantification by BiomX.

Paper: A phage receptor-binding protein as a promising tool for the detection of Escherichia coli in human specimens.

Paper: A novel bacteriophage cocktail targeting Staphylococcus aureus and MRSA biofilms.

Webinar: Embracing the Australian Pathway to Phage Therapy in Canada: Connect Globally, Act Locally. Hosted by AMMI (Association of Medical Microbiology and Infectious Disease Canada) Tuesday, June 28th at 6pm - 7pm EDT Ottawa (Wednesday,

Phage Australia's new website is live at phageaustralia.org! Phage Australia is a national network of phage researchers and clinician scientists who aim to professionalise phage therapy as the third major intervention for infectious diseas

iVoM Season 2, hosted by ISVM, VoM 2022 and Phage Directory concluded recently with its 7th event. The recordings of all the events are now posted on the members page! The events spanned all aspects of viruses of microbes, and each featur

Pre-print: Subtherapeutic doses of vancomycin synergize with bacteriophages for treatment of experimental methicillin-resistant Staphylococcus aureus infective endocarditis

Paper: PhREEPred: Phage Resistance Emergence Prediction web to foresee encapsulated bacterial escape from phage cocktail treatment

Paper: Diversity of lytic bacteriophages against XDR Klebsiella pneumoniae sequence type 16 recovered from sewage samples in different parts of the world

Paper: Suggestion for a new bacteriophage genus for the Klebsiella pneumoniae phage vB_KpnS-Carvaje

Paper: Topical liquid formulation of bacteriophages for metered-dose spray delivery

We warmly invite you to attend you to attend our 12th annual Oxford bacteriophage conference – the longest running phage conferences series in Europe – which will be held on 05-06 September 2022. We are committed to holding this conference

iVoM Season 2, hosted by ISVM, VoM 2022 and Phage Directory concluded recently with its 7th event. The recordings of all the events are now posted on the members page! The events spanned all aspects of viruses of microbes, and each featur

We warmly invite you to attend you to attend our 12th annual Oxford bacteriophage conference – the longest running phage conferences series in Europe – which will be held on 05-06 September 2022. We are committed to holding this conference

Hi everyone, I have isolated a few phages - 2 are Jumbo phage. I have sequnced (350 kbp) these phages. I need help in sequence analysis and can collaboratively publish it. Email: avtar2020@gmail.com

I was wondering if there was an unpublished case of a phage therapy done which I could write a case report about. If so please contact me at nameerap26@gmail.com

Adaptive Phage Therapeutics announced that the first patient has been dosed in its DFO Adaptive Novel Care Evaluation (DANCE™) trial, a Phase 1/2 clinical study to evaluate the safety and efficacy of APT’s precision phage therapy in patient